Miltenyi Biotec
Miltenyi Biotec home - back to start page
Miltenyi Biotec
  • MACS® Cell Analysis
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Cell separation reagents Cell separation reagents
  for human cells
  for non-human primate cells
  for mouse cells
  Stem and progenitor cells
  Neural cells
  T cells
  NK cells
  B cells
  Monocytes and macrophages
  Myeloid derived suppressor cells
  Dendritic cells
  Antigen-presenting cells
  Granulocytes
  Leukocytes
  Endothelial cells
  Erythroid cells
  Cytokine-producing cells
  for rat cells
  for indirect magnetic labeling
  for apoptotic and dead cells
  for isolation of mitochondria
Manual cell separation Manual cell separation
Automated cell separation Automated cell separation
MACS® Technology MACS® Technology
Miltenyi Biotec
MACS eNews
Subscribe to our
MACS eNews
for regular product information via e-mail.
Miltenyi Biotec
Myeloid-Derived Suppressor Cell Isolation Kit
Overview
The Myeloid-Derived Suppressor Cell Isolation Kit has been developed for the isolation of Gr-1highLy-6G+ and Gr-1dimLy-6G myeloid cells from lymphoid tissue.
Details
Background information
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells, characterized as CD11b+Gr-1+, with a remarkable capacity to induce T cell dysfunction. They arise in various pathological conditions (cancer, infection, autoimmune diseases), where the differentiation of immature myeloid progenitor cells into granulocytes, macrophages, or dendritic cells is partially blocked.
Gr-1dimLy-6G cells can be further subdivided according to the expression of Ly-6C into Gr-1dimLy-6ChighLy-6G and Gr-1dimLy-6ClowLy-6G cells. The proportion of Ly-6Chigh and Ly-6Clow cells varies among tumor models.

Detailed separation procedure
The Myeloid-Derived Suppressor Cell Isolation Kit has been developed for the isolation of Gr-1highLy-6G+ and Gr-1dimLy-6G myeloid cells.

First, the cell suspension is incubated with an Anti-Ly-6G-Biotin antibody and Anti-Biotin MicroBeads. The cells are subsequently applied to a MACS Column, which retains the magnetically labeled Gr-1highLy-6G+ cells. The unlabeled cells flow through; this cell fraction contains Gr-1dimLy-6G myeloid cells. The magnetically labeled Gr-1highLy-6G+ cells can be eluted as the positively selected cell fraction and are further purified by applying them to a second MACS Column.

Second, the pre-enriched Gr-1dimLy-6G subpopulation is further purified. To this end, the cells are incubated with an Anti-Gr-1-Biotin antibody and Streptavidin MicroBeads, and isolated by positive selection over two MACS Columns.

Downstream applications
MDSCs isolated with this kit can be used for functional analyses, such as T cell activation and effector function in experimental animal models. Isolated MDSCs are also suitable for, e.g., phenotypical analysis or downstream gene expression profiling.
Columns
For the first magnetic separation: LS or autoMACS® Columns; for second magnetic separation: MS or autoMACS Columns.
 
Figure 1
Myeloid-derived suppressor cells were isolated from a spleen of a BALB/c mouse using the Myeloid-Derived Suppressor Cell Isolation Kit, two LS Columns, two MS Columns, and an appropriate MACS Separator. Cells were fluorescently stained with CD11b-APC and Anti-Gr-1-PE and analyzed by flow cytometry. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence.
Spleen cells before separation
Enriched Gr-1highLy-6G+ cells
Enriched Gr-1dimLy-6G cells
Miltenyi Biotec
Search this website
Advanced search
Toolbox
Customer login
Contact
Newsletter
Help
Favorites / Prices
Request prices or add products to your favorite list.
Details
Products
Myeloid-Derived Suppressor Cell Isolation Kit, mouse
- for 2×109 total cells
Download datasheet
130-094-538
Qty.:
 

Related products
Anti-Gr-1 Antibodies
Anti-Ly-6G Antibodies
CD11b Antibodies
Anti-Ly-6C Antibodies
Anti-Ly-6G MicroBead Kit
References
1. Serafini, R. et al. (2004) Cancer Immunol Immunother 53: 64–72.
2. Youn, J. et al. (2008) J. Immunol. 181: 5791–5802.
3. 3. Ostrand-Rosenberg, S. and Sinha, P. (2009) J. Immunol. 182: 4499–4506.
4. Gabrilovich, D. I. and Nagaraj, S. (2009) Nat. Rev. Immunol. 9: 162–174.
5. Bronte, V. et al. (1999) J. Immunol. 162: 5728–5737.
6. Movahedi, K. et al. (2008) Blood 111: 4233–4244.
Miltenyi Biotec
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
Miltenyi Biotec website